Cargando…

An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells

Sorafenib resistance remains a major obstacle for the effective treatment of hepatocellular carcinoma (HCC), and a number of miRNAs contribute to this resistance. However, the regulatory networks of miRNAs are very complex, thus inhibiting a single miRNA may sequentially activate other compensatory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Shuyao, Tan, Gang, Jiang, Xian, Han, Peng, Zhai, Bo, Dong, Xuesong, Qiao, Haiquan, Jiang, Hongchi, Sun, Xueying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341977/ https://www.ncbi.nlm.nih.gov/pubmed/27689326 http://dx.doi.org/10.18632/oncotarget.12304

Ejemplares similares

LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
por: Li, Weidong, et al.
Publicado: (2019)

Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
por: Li, Weidong, et al.
Publicado: (2021)

Dual inhibition of Akt and c‐Met as a second‐line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells
por: Han, Peng, et al.
Publicado: (2017)

MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway
por: He, Changjun, et al.
Publicado: (2015)

Sodium orthovanadate overcomes sorafenib resistance of hepatocellular carcinoma cells by inhibiting Na(+)/K(+)-ATPase activity and hypoxia-inducible pathways
por: Jiang, Wenjing, et al.
Publicado: (2018)

Downregulation of developmentally regulated endothelial cell locus-1 inhibits the growth of colon cancer
por: Zou, Xiaolong, et al.
Publicado: (2008)

Meloxicam Executes Its Antitumor Effects against Hepatocellular Carcinoma in COX-2- Dependent and -Independent Pathways
por: Dong, Xiaofeng, et al.
Publicado: (2014)

The Inhibitory Role of B7-H4 in Antitumor Immunity: Association with Cancer Progression and Survival
por: He, Changjun, et al.
Publicado: (2011)

Hydrogen Sulfide Attenuates Carbon Tetrachloride-Induced Hepatotoxicity, Liver Cirrhosis and Portal Hypertension in Rats
por: Tan, Gang, et al.
Publicado: (2011)

Oncogenic lncRNA BBOX1-AS1 promotes PHF8-mediated autophagy and elicits sorafenib resistance in hepatocellular carcinoma
por: Tao, Haisu, et al.
Publicado: (2022)

Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer
por: Li, Yongsheng, et al.
Publicado: (2015)

Polycystic Ovary Syndrome: Novel and Hub lncRNAs in the Insulin Resistance-Associated lncRNA–mRNA Network
por: Zhao, Jun, et al.
Publicado: (2019)

Knockdown of lncRNA TP53TG1 Enhances the Efficacy of Sorafenib in Human Hepatocellular Carcinoma Cells
por: Lu, Qingchun, et al.
Publicado: (2022)

RBM38 Reverses Sorafenib Resistance in Hepatocellular Carcinoma Cells by Combining and Promoting lncRNA-GAS5
por: Gao, Xing, et al.
Publicado: (2023)

The etiological roles of miRNAs, lncRNAs, and circRNAs in neuropathic pain: A narrative review
por: Jiang, Ming, et al.
Publicado: (2022)

LncRNA–miRNA–mRNA Networks of Gastrointestinal Cancers Representing Common and Specific LncRNAs and mRNAs
por: Dastsooz, Hassan, et al.
Publicado: (2022)

A novel lncRNA-miRNA-mRNA triple network identifies lncRNA TWF1 as an important regulator of miRNA and gene expression in coronary artery disease
por: Miao, Liu, et al.
Publicado: (2019)

Epigenetic Associations between lncRNA/circRNA and miRNA in Hepatocellular Carcinoma
por: Han, Tae-Su, et al.
Publicado: (2020)

Transcriptomic Analysis of mRNA-lncRNA-miRNA Interactions in Hepatocellular Carcinoma
por: Tang, Xia, et al.
Publicado: (2019)

LncRNA CRNDE Promotes ATG4B-Mediated Autophagy and Alleviates the Sensitivity of Sorafenib in Hepatocellular Carcinoma Cells
por: Chen, Lingxi, et al.
Publicado: (2021)

The functional sites of miRNAs and lncRNAs in gastric carcinogenesis
por: Wan, Xiangxiang, et al.
Publicado: (2015)

Identification of cancer-related miRNA-lncRNA biomarkers using a basic miRNA-lncRNA network
por: Zhang, Guangle, et al.
Publicado: (2018)

Construction of lncRNA-miRNA-mRNA networks reveals functional lncRNAs in abdominal aortic aneurysm
por: Tian, Lu, et al.
Publicado: (2018)

Construction of a lncRNA-miRNA-mRNA network to determine the regulatory roles of lncRNAs in psoriasis
por: Zhou, Qianqian, et al.
Publicado: (2019)

Reconstruction of the lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in Cerebral Infarction
por: Zou, Jun-Bo, et al.
Publicado: (2019)

Non‑coding RNAs: Role of miRNAs and lncRNAs in the regulation of autophagy in hepatocellular carcinoma (Review)
por: Wu, Jia, et al.
Publicado: (2023)

Predicting lncRNA–Protein Interactions With miRNAs as Mediators in a Heterogeneous Network Model
por: Zhou, Yuan-Ke, et al.
Publicado: (2020)

Detecting lncRNA–Cancer Associations by Combining miRNAs, Genes, and Prognosis With Matrix Factorization
por: Yan, Huan, et al.
Publicado: (2021)

LncRNA HEIH Confers Cell Sorafenib Resistance in Hepatocellular Carcinoma by Regulating miR-98-5p/PI3K/AKT Pathway
por: Shen, Qian, et al.
Publicado: (2020)

LncRNA DANCR Promotes Sorafenib Resistance via Activation of IL-6/STAT3 Signaling in Hepatocellular Carcinoma Cells
por: Liu, Yuan, et al.
Publicado: (2020)

LncRNA Riken‐201 and Riken‐203 modulates neural development by regulating the Sox6 through sequestering miRNAs
por: Zhang, Lei, et al.
Publicado: (2019)

miRNAs and lncRNAs in Echinococcus and Echinococcosis
por: He, Zhi, et al.
Publicado: (2020)

Portrait of Tissue-Specific Coexpression Networks of Noncoding RNAs (miRNA and lncRNA) and mRNAs in Normal Tissues
por: Cava, Claudia, et al.
Publicado: (2019)

Construction of lncRNA‐miRNA‐mRNA network based on ceRNA mechanism reveals the function of lncRNA in the pathogenesis of gout
por: Chen, Feng, et al.
Publicado: (2022)

TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma
por: Lai, Hui‐Huang, et al.
Publicado: (2019)

A Novel atTAK Against Hepatocellular Carcinoma: Overcoming Resistance to Sorafenib
por: Pietrobono, Silvia, et al.
Publicado: (2021)

Analysis of PANoptosis-Related LncRNA-miRNA-mRNA Network Reveals LncRNA SNHG7 Involved in Chemo-Resistance in Colon Adenocarcinoma
por: Huang, Jingjing, et al.
Publicado: (2022)

LncRNA TTN-AS1 promotes the progression of cholangiocarcinoma via the miR-320a/neuropilin-1 axis
por: Zhu, Huaqiang, et al.
Publicado: (2020)

miRNA and lncRNA as biomarkers in cholangiocarcinoma(CCA)
por: Zheng, Bo, et al.
Publicado: (2017)

The role of miRNA and lncRNA in gastric cancer
por: Hao, Ning-Bo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_khemijupa2p3jb8lfvfbn2m262